Intravascular Catheters

Global Intravascular Catheters Market to Reach US$15.1 Billion by 2030

The global market for Intravascular Catheters estimated at US$7.6 Billion in the year 2024, is expected to reach US$15.1 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2024-2030. Short PIVC, one of the segments analyzed in the report, is expected to record a 13.4% CAGR and reach US$10.9 Billion by the end of the analysis period. Growth in the Integrated / Closed PIVC segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 16.4% CAGR

The Intravascular Catheters market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 10.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Intravascular Catheters Market – Key Trends & Drivers Summarized

How Are Intravascular Catheters Revolutionizing Medical Procedures?

The intravascular catheters market is witnessing significant growth due to increasing demand for minimally invasive procedures, advancements in catheter technology, and rising prevalence of chronic diseases requiring vascular access. Intravascular catheters are essential for a wide range of medical applications, including drug administration, fluid infusion, hemodialysis, cardiovascular interventions, and critical care monitoring. These catheters provide safe, efficient, and precise access to blood vessels, reducing complications associated with traditional surgical interventions.

With the global rise in cardiovascular diseases (CVDs), cancer treatments, and end-stage renal disease (ESRD) requiring dialysis, intravascular catheter adoption is increasing across hospitals, ambulatory surgical centers, and home healthcare settings. Additionally, the growth of interventional cardiology, neurology, and radiology has expanded the use of specialized guiding catheters, balloon catheters, and microcatheters for precision-based procedures such as angioplasty, stent placement, and thrombectomy.

Technological advancements, such as antimicrobial-coated catheters, bioabsorbable catheters, and catheter navigation systems, are enhancing infection control, patient safety, and procedural efficiency. The shift toward minimally invasive treatments, coupled with the increasing use of catheter-based therapies in outpatient settings, is expected to drive continued market expansion.

What Are the Key Trends Shaping the Intravascular Catheters Market?

One of the most notable trends in the intravascular catheters market is the development of antimicrobial and heparin-coated catheters. Catheter-associated bloodstream infections (CLABSIs) and thrombosis are major complications in long-term catheter use, leading to increased hospitalizations and mortality rates. To address this, manufacturers are introducing catheters embedded with silver-ion, chlorhexidine, and antimicrobial coatings to reduce infection risks and improve catheter longevity.

Another key trend is the integration of smart sensors and real-time monitoring capabilities in catheters. Smart catheters equipped with pressure sensors, wireless connectivity, and microfluidic technology are enabling continuous hemodynamic monitoring, early detection of blockages, and improved fluid management. These innovations are particularly valuable in intensive care units (ICUs) and interventional cardiology, where real-time patient data can significantly improve outcomes.

The increasing adoption of peripherally inserted central catheters (PICCs) and midline catheters is also reshaping the market. PICCs offer an alternative to central venous catheters (CVCs) for long-term intravenous therapy, reducing the need for repeated venipunctures. Midline catheters, which provide intermediate vascular access, are gaining traction in outpatient settings and home healthcare, enabling cost-effective, extended IV therapy without the risks associated with central line infections.

Another emerging trend is the use of biodegradable and bioresorbable catheters. Traditional polymer-based catheters can cause foreign body reactions and thrombosis, whereas biodegradable catheters dissolve over time, minimizing long-term complications. This innovation is particularly beneficial in temporary catheter placements, neurovascular interventions, and pediatric applications where minimizing residual foreign material is critical.

Additionally, the rise in interventional and diagnostic catheterization procedures is driving demand for microcatheters and steerable guiding catheters. These specialized devices are widely used in angioplasty, embolization, neurointerventions, and electrophysiology procedures, allowing precise navigation through complex vascular structures. The increasing adoption of robot-assisted catheter navigation systems is further enhancing accuracy, efficiency, and procedural success rates in catheter-based interventions.

What Challenges Are Impacting the Intravascular Catheters Market?

Despite the numerous advancements in intravascular catheter technology, several challenges hinder widespread adoption and market growth. One of the primary concerns is catheter-related infections and thrombosis, which can lead to serious complications, extended hospital stays, and increased healthcare costs. While antimicrobial coatings and advanced catheter materials help reduce infection risks, strict aseptic techniques and regular catheter maintenance are essential to prevent complications.

Another major challenge is the high cost of advanced catheterization devices and procedures. Drug-eluting catheters, bioresorbable catheters, and sensor-integrated catheters come at a premium cost, making them less accessible in low-income regions. Additionally, reimbursement limitations for advanced catheter-based procedures in certain countries can restrict patient access to cutting-edge treatments.

Regulatory hurdles and stringent approval processes pose another challenge for market players. Medical device regulatory authorities such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Pharmaceuticals and Medical Devices Agency, Japan) impose strict clinical trial requirements for new catheter technologies, coatings, and materials. The time-consuming approval process can delay product launches and increase development costs.

Material biocompatibility and catheter durability are also key concerns. Catheters made from silicone, polyurethane, and PTFE (polytetrafluoroethylene) must exhibit optimal flexibility, kink resistance, and hemodynamic stability to prevent clot formation and vessel trauma. Balancing softness with durability while ensuring low thrombogenicity remains a technical challenge for manufacturers.

Additionally, the shortage of skilled healthcare professionals trained in advanced catheterization procedures is a limiting factor in some regions. Interventional cardiologists, radiologists, and vascular surgeons require specialized training to handle complex catheter-based interventions, and the lack of expertise can impact procedural success rates.

What Factors Are Driving the Growth of the Intravascular Catheters Market?

The growth in the intravascular catheters market is driven by several factors, including the rising incidence of cardiovascular diseases, the increasing use of minimally invasive interventions, and continuous innovations in catheter technology. One of the major drivers is the growing prevalence of cardiovascular disorders, such as coronary artery disease (CAD), stroke, and peripheral artery disease (PAD), which require catheter-based interventions such as angioplasty, stenting, and thrombectomy.

Another key driver is the expanding applications of catheters in oncology, nephrology, and neurology. Catheter-based chemotherapy infusion, dialysis catheters for end-stage renal disease (ESRD), and neurovascular catheters for stroke treatment are contributing to market growth. The rising global burden of cancer and kidney diseases is driving demand for long-term vascular access devices.

The increasing adoption of outpatient and home-based infusion therapies is further fueling market expansion. Peripherally inserted central catheters (PICCs) and midline catheters are being widely used for long-term antibiotic therapy, chemotherapy, and parenteral nutrition, allowing patients to receive treatment outside of hospital settings. This trend is particularly significant in chronic disease management and elderly patient care, where home-based IV therapy reduces hospital admissions and healthcare costs.

Technological advancements, such as robotic-assisted catheter navigation, real-time pressure-sensing catheters, and 3D imaging-assisted catheter placement, are enhancing the precision and safety of minimally invasive vascular procedures. The introduction of AI-driven catheter placement guidance systems is helping reduce complications, improve procedural outcomes, and shorten procedure times.

Additionally, government initiatives and healthcare investments in improving vascular access care and catheter-based treatment infrastructure are supporting market growth. Many developing countries are expanding interventional cardiology and dialysis centers, increasing the adoption of high-quality intravascular catheters and vascular access solutions.

With ongoing advancements in catheter coatings, biodegradable materials, smart sensors, and AI-driven imaging, the intravascular catheters market is poised for continuous growth and innovation. Companies that focus on infection control, cost-effective solutions, and regulatory compliance will gain a competitive advantage in meeting the evolving needs of healthcare providers and patients worldwide.

SCOPE OF STUDY:

The report analyzes the Intravascular Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Short PIVC, Integrated / Closed PIVC); Application (Oncology, Gastroenterology, Renal Disease, Infectious Diseases, Others); End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, Homecare, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• AMECATH
• AngioDynamics, Inc.
• Angiplast Pvt. Ltd.
• Argon Medical Devices, Inc.
• Asahi Kasei Corporation
• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• Boston Scientific Corporation
• Cook Medical
• Edwards Lifesciences Corporation
• Hindustan Syringes & Medical Devices Ltd.
• ICU Medical, Inc.
• Johnson & Johnson
• McKesson Corporation
• Medline Industries, Inc.
• Medtronic PLC
• Nipro Medical Corporation
• PRODiMED
• Romsons Scientific & Surgical Pvt. Ltd.
• Smiths Medical

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.